WallStreetZenWallStreetZen

NASDAQ: ATRA
Atara Biotherapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Atara Biotherapeutics earnings were $23.4M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest ATRA earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$4.3M, down 280.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ATRA reported annual earnings of -$85.4M, with -69.1% growth.

ATRA earnings history

Current Revenue
$151.9M
Current Earnings
$23.4M
Current Profit Margin
15.4%
ATRA's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ATRA Return on Equity

Current Company
-41.8%
Current Industry
-21.2%
Current Market
35.1%
ATRA's Return on Equity (-41.8%)... subscribe to Premium to read more.
High Return on Equity Performance

ATRA Return on Assets

Current Company
39.3%
Current Industry
-8.8%
ATRA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ATRA announces earnings.

ATRA Return on Capital Employed

Current Company
225.66%
Current Industry
-3.5%
ATRA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATRA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ATRA$38.25M$23.40MN/A$3.34
ANIX-$11.08M-$11.12MN/A-$0.35
HYFT-$21.06M-$21.62MN/A-$0.62
MGNX-$64.40M-$75.89MN/A-$1.20
SAVA-$105.20M-$106.03MN/A-$2.22
View Top Biotech Stocks

Atara Biotherapeutics Earnings Reports & History FAQ

What were Atara Biotherapeutics's earnings last quarter?

Atara Biotherapeutics (NASDAQ: ATRA) reported Q3 2025 earnings per share (EPS) of -$0.32, up 89.08% year over year. Total ATRA earnings for the quarter were -$4.30 million. In the same quarter last year, Atara Biotherapeutics's earnings per share (EPS) was -$2.93.

If you're new to stock investing, here's how to buy Atara Biotherapeutics stock.

Is Atara Biotherapeutics profitable or losing money?

As of the last Atara Biotherapeutics earnings report, Atara Biotherapeutics is currently profitable. Atara Biotherapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $23.40 million, a 117.57% decrease year over year.

What was ATRA's earnings growth in the past year?

As of Atara Biotherapeutics's earnings date in Q1 2026, Atara Biotherapeutics's earnings has grown year over year. ATRA earnings in the past year totalled $23.40 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.